TS

Tristel PLCOOTC TSNLF Stock Report

Last reporting period 31 Dec, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

0.262

Micro

Exchange

OOTC - OTC

TSNLF Stock Analysis

TS

Attractive

Based on Eyestock quantitative analysis, TSNLF`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

111/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

11615.2 %

Undervalued

Market cap $B

0.262

Dividend yield

2.85 %

Shares outstanding

47.248 B

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 199 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination, Hospital environmental surface disinfection and other. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The firm is focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health.

View Section: Eyestock Rating